44 related articles for article (PubMed ID: 19026704)
1. The temperature-sensitive mutants of Toxoplasma gondii and ocular toxoplasmosis.
Lu F; Huang S; Kasper LH
Vaccine; 2009 Jan; 27(4):573-80. PubMed ID: 19026704
[TBL] [Abstract][Full Text] [Related]
2. An Important Role for CD4
Tussiwand R; Behnke MS; Kretzer NM; Grajales-Reyes GE; Murphy TL; Schreiber RD; Murphy KM; Sibley LD
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669460
[TBL] [Abstract][Full Text] [Related]
3. Long-term immunity to lethal acute or chronic type II Toxoplasma gondii infection is effectively induced in genetically susceptible C57BL/6 mice by immunization with an attenuated type I vaccine strain.
Gigley JP; Fox BA; Bzik DJ
Infect Immun; 2009 Dec; 77(12):5380-8. PubMed ID: 19797073
[TBL] [Abstract][Full Text] [Related]
4. Animal Models for Toxoplasma gondii Infection.
S Subauste C; Hubal A
Curr Protoc; 2023 Sep; 3(9):e871. PubMed ID: 37695167
[TBL] [Abstract][Full Text] [Related]
5. Immunological Molecular Responses of Human Retinal Pigment Epithelial Cells to Infection With
Lie S; Rochet E; Segerdell E; Ma Y; Ashander LM; Shadforth AMA; Blenkinsop TA; Michael MZ; Appukuttan B; Wilmot B; Smith JR
Front Immunol; 2019; 10():708. PubMed ID: 31118929
[TBL] [Abstract][Full Text] [Related]
6.
Khan IA; Hwang S; Moretto M
Front Cell Infect Microbiol; 2019; 9():136. PubMed ID: 31119107
[No Abstract] [Full Text] [Related]
7. Laboratory passage and characterization of an isolate of Toxoplasma gondii from an ocular patient in Korea.
Chai JY; Lin A; Shin EH; Oh MD; Han ET; Nan HW; Lee SH
Korean J Parasitol; 2003 Sep; 41(3):147-54. PubMed ID: 12972728
[TBL] [Abstract][Full Text] [Related]
8. New advances in immune mechanism and treatment during ocular toxoplasmosis.
Chen Z; Cheng S; Chen X; Zhang Z; Du Y
Front Immunol; 2024; 15():1403025. PubMed ID: 38799473
[TBL] [Abstract][Full Text] [Related]
9. Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels.
de-la-Torre A; Sauer A; Pfaff AW; Bourcier T; Brunet J; Speeg-Schatz C; Ballonzoli L; Villard O; Ajzenberg D; Sundar N; Grigg ME; Gomez-Marin JE; Candolfi E
PLoS Negl Trop Dis; 2013 Nov; 7(11):e2541. PubMed ID: 24278490
[TBL] [Abstract][Full Text] [Related]
10. Immunity and Toxoplasma retinochoroiditis.
Wallace GR; Stanford MR
Clin Exp Immunol; 2008 Sep; 153(3):309-15. PubMed ID: 18549442
[TBL] [Abstract][Full Text] [Related]
11. Elevated interleukin-10 levels in patients with ocular toxoplasmosis.
Kim GH; Kwak JH; Park YH
Parasites Hosts Dis; 2023 Aug; 61(3):310-316. PubMed ID: 37648237
[TBL] [Abstract][Full Text] [Related]
12. miRNA 511_5p is a potential biomarker for ocular toxoplasmosis.
de Faria Júnior GM; Kumano LS; Bronchtein Gomes I; Camargos GS; Meira-Strejevitch CDS; Castiglioni L; Previato M; Pereira-Chioccola VL; Brandão CC; de Mattos LC
Trans R Soc Trop Med Hyg; 2023 Nov; 117(11):804-810. PubMed ID: 37477502
[TBL] [Abstract][Full Text] [Related]
13. Brain-localized CD4 and CD8 T cells perform correlated random walks and not Levy walks.
Patel D; Lin R; Majumder B; Ganusov VV
F1000Res; 2023; 12():87. PubMed ID: 37811200
[No Abstract] [Full Text] [Related]
14. Uncovering a novel role of PLCβ4 in selectively mediating TCR signaling in CD8+ but not CD4+ T cells.
Sasai M; Ma JS; Okamoto M; Nishino K; Nagaoka H; Takashima E; Pradipta A; Lee Y; Kosako H; Suh PG; Yamamoto M
J Exp Med; 2021 Jul; 218(7):. PubMed ID: 33970189
[TBL] [Abstract][Full Text] [Related]
15. Sixty Years (1957-2017) of Research on Toxoplasmosis in China-An Overview.
Pan M; Lyu C; Zhao J; Shen B
Front Microbiol; 2017; 8():1825. PubMed ID: 28993763
[No Abstract] [Full Text] [Related]
16. Toxoplasma Gondii Infection of Chicken Embryos Causes Retinal Changes and Modulates HSP90B1 Gene Expression: A Promising Ocular Toxoplasmosis Model.
Nasaré AM; Tedesco RC; Cristovam PC; Cenedese MA; Galisteo AJ; Andrade HF; Gomes JÁ; Guimarães ÉV; Barbosa HS; Alonso LG
Eur J Microbiol Immunol (Bp); 2015 Dec; 5(4):316-20. PubMed ID: 26716020
[TBL] [Abstract][Full Text] [Related]
17. Experimental Models of Ocular Infection with Toxoplasma Gondii.
Dukaczewska A; Tedesco R; Liesenfeld O
Eur J Microbiol Immunol (Bp); 2015 Dec; 5(4):293-305. PubMed ID: 26716018
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the adjuvant effect of pidotimod on the immune protection induced by UV-attenuated Toxoplasma gondii in mouse models.
Zhao Y; Huang B; Huang S; Zheng H; Li YQ; Lun ZR; Shen J; Wang Y; Kasper LH; Lu F
Parasitol Res; 2013 Sep; 112(9):3151-60. PubMed ID: 23783399
[TBL] [Abstract][Full Text] [Related]
19. ATF6beta is a host cellular target of the Toxoplasma gondii virulence factor ROP18.
Yamamoto M; Ma JS; Mueller C; Kamiyama N; Saiga H; Kubo E; Kimura T; Okamoto T; Okuyama M; Kayama H; Nagamune K; Takashima S; Matsuura Y; Soldati-Favre D; Takeda K
J Exp Med; 2011 Jul; 208(7):1533-46. PubMed ID: 21670204
[TBL] [Abstract][Full Text] [Related]
20. Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8+T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii.
Cong H; Mui EJ; Witola WH; Sidney J; Alexander J; Sette A; Maewal A; McLeod R
Immunome Res; 2010 Dec; 6():12. PubMed ID: 21129215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
